Granulocyte colony stimulating factor treatment for alloimmune neonatal neutropenia.
Granulocyte colony stimulating factor (G-CSF) treatment was successfully used in three preterm infants with alloimmune neonatal neutropenia (AINN). Two infants had persistent neutropenia despite treatment with intravenous immunoglobulin and random donor granulocyte transfusions for presumed sepsis. Neutrophil counts returned to normal with G-CSF treatment; the response was least convincing in one infant with fulminant necrotising enterocolits. It is suggested that treatment with G-CSF be considered early for the treatment of infants with AINN.
Rodwell
R L
RL
Division of Haematology, Mater Misericordiae Hospitals, South Brisbane 4101, Australia.
Gray
P H
PH
Taylor
K M
KM
Minchinton
R
R
D000906:Antibodies / Q000097:blood; D005260:Female; D005312:Fetal Blood / Q000276:immunology; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage*; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000276:immunology / Q000628:therapy*; D007279:Injections, Subcutaneous; D007958:Leukocyte Count; D008297:Male; D009503:Neutropenia / Q000276:immunology / Q000628:therapy*; D009504:Neutrophils / Q000276:immunology
D000906:Antibodies; D016179:Granulocyte Colony-Stimulating Factor